@article{article, title  = {{Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS}},

 publisher = {{Massachusetts Medical Society}},

 url = {{https://eprints.whiterose.ac.uk/163772/ }},

 year = {{2020}},

 month = {{7}},

 author = {{Miller T and Cudkowicz M and Shaw PJ and Andersen PM and Atassi N and Bucelli RC and Genge A and Glass J and Ladha S and Ludolph AL and Maragakis NJ et al}},

 doi = {{10.1056/nejmoa2003715}},

 volume = {{383}},

 journal = {{New England Journal of Medicine}},

 issue = {{2}},

 pages = {{109-119}},

 note = {{Accessed on 2024/12/26}}}